Insider Transactions in Q4 2023 at Phathom Pharmaceuticals, Inc. (PHAT)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2023
|
Molly Henderson CFO and CBO |
SELL
Open market or private sale
|
Direct |
2,127
-2.02%
|
$14,889
$7.24 P/Share
|
|
Nov 08
2023
|
Asit Parikh |
BUY
Open market or private purchase
|
Direct |
2,500
+4.35%
|
$17,500
$7.8 P/Share
|
|
Nov 07
2023
|
Asit Parikh |
BUY
Open market or private purchase
|
Direct |
4,000
+7.08%
|
$28,000
$7.76 P/Share
|
|
Nov 06
2023
|
Asit Parikh |
BUY
Open market or private purchase
|
Direct |
1,000
+2.02%
|
$8,000
$8.04 P/Share
|
|
Nov 01
2023
|
Molly Henderson CFO and CBO |
SELL
Open market or private sale
|
Direct |
12,492
-5.34%
|
$99,936
$8.38 P/Share
|
|
Nov 01
2023
|
Molly Henderson CFO and CBO |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+16.05%
|
-
|
|
Nov 01
2023
|
Terrie Curran President and Chief Executive |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+8.07%
|
-
|
|
Nov 01
2023
|
Azmi Nabulsi Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,500
+11.84%
|
-
|